McKesson To Buy Vantage Oncology And Biologics Inc. - Quick Facts

(RTTNews) - McKesson Corp. (MCK) announced it has signed definitive agreements to purchase Vantage Oncology, LLC, a leading national provider of radiation oncology, medical oncology and integrated cancer care, and Biologics, Inc., an oncology pharmacy services company. The combined transactions are valued at $1.2 billion. Both Vantage and Biologics will become part of McKesson's Specialty Health business.

McKesson expects the combined impact of the transactions to be approximately 11 cents accretive to adjusted earnings per share in fiscal 2017.

Manhattan Beach, California-based Vantage Oncology, LLC is a leading national provider of radiation oncology, medical oncology and other value-based integrated cancer care services. Vantage Oncology currently operates more than 50 treatment facilities in 13 states.

Biologics, Inc. is an oncology pharmacy services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes - clinical, financial and emotional. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina.

McKesson said these acquisitions will increase its specialty pharmaceutical distribution scale, oncology-focused pharmacy offerings, solutions for manufacturers and payers, and scope of community-based oncology and practice management services available to providers and patients.